Since the price went up that would be more buys. Did you not take economics 101?
Analysis paralysis. They are trying to expand on their existing technologies. I don't think pundit would want to tarnish his reputation by using such unethical business practices.
Nothing against Brother Bear but he brought him over from ZIOP.
There was no difference since they were not using Lymphoseek. Why is there a 90% retention rate if its useless?
Check out ALQA. It was trading @ .08 pre-split which equates to 3.50 after the RS. Now they are trading at 7.40 close today. Also there are revenue requirements to list on a national exchange so that is why it would not be likely for this stock to benefit from a RS. Revenue stream not likely for while with this company.
Management is doing a spectacular job. Hopefully it will end up in a bidding war between the two. That would be ideal.